Chief Medical Officer & VP and General Manager of Enterprise Healthcare, Samsung Electronics America
Dr. David Rhew is the Chief Medical Officer (CMO) and Head of Healthcare and Fitness for Samsung Electronics of America. David received his Bachelors of Science degrees in computer science and cellular molecular biology from the University of Michigan. He received his MD degree from Northwestern University and completed internal medicine residency at Cedars-Sinai Medical Center. He completed fellowships in health services research at Cedars-Sinai Medical Center and infectious diseases at the University of California, Los Angeles.
Dr. Rhew has served as CMO and Vice-President for Global Healthcare at Samsung SDS; Senior Vice-President and CMO at Zynx Health Incorporated; clinician/researcher in the Division of Infectious Diseases at the VA Greater Los Angeles Healthcare System; and Associate Clinical Professor of Medicine at UCLA. Dr. Rhew has served on the National Quality Forum’s (NQF) Steering Committee for Pulmonary and Critical Care quality indicators and is currently on the NQF Consensus Standards and Approval Committee. He co-holds six U.S. technology patents that enable the authoring, mapping, and integration of clinical decision support into the electronic health record.
Dr. Rhew’s interests include measurably improving the quality, safety, and efficiency of patient care and applying technology to engage patients and consumers in their health.
Managing Director, Life Sciences & Head Predictive Health Intelligence, Accenture Strategy
Jeff Elton is managing director and global head, Predictive Health Intelligence. He has over 20 years of experience as a global executive and consultant in the biopharmaceutical and healthcare sectors. Prior to Accenture, he was global COO and SVP Strategy for the Novartis Institutes of BioMedical Research overseeing R&D operations in the US, Europe and Asia.
Prior to Novartis Jeff was a senior partner at McKinsey in the Medical Products & Pharmaceuticals practice, focused on R&D. He was also founding CEO, board member and senior advisor to five early stage companies in personalized oncology management, oncology diagnostics, protein therapeutics, neurodegenerative diseases, diabetes and nanotherapeutics.
Jeff holds a Ph.D. in Business Economics and Marketing and an MBA in Finance and Statistics from the University of Chicago Booth School of Business.